Literature DB >> 19538961

Remyelination - An effective means of neuroprotection.

Charlotte C Bruce1, Chao Zhao, Robin J M Franklin.   

Abstract

Remyelination following central nervous system (CNS) demyelination restores rapid saltatory conduction of action potentials and contributes to the maintenance of axonal integrity. This robust regenerative phenomenon stands in contrast to the limited repair capacity that is characteristic of CNS neuronal injury. However, despite its efficiency in experimental models and some clinical diseases, remyelination failure becomes an increasingly pronounced feature of the pathology of chronic multiple sclerosis (MS) lesions. Chronic demyelination predisposes axons to atrophy, an irreversible event that is a major pathological correlate of progressive functional decline. This has created a compelling case for developing therapies that promote remyelination: evidence from experimental animal models suggests that hormones may have a beneficial role to play in this regard. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538961     DOI: 10.1016/j.yhbeh.2009.06.004

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  26 in total

1.  Mesenchymal stem cells prime proliferating adult neural progenitors toward an oligodendrocyte fate.

Authors:  Carolin Steffenhagen; Franz-Xaver Dechant; Eleni Oberbauer; Tanja Furtner; Norbert Weidner; Patrick Küry; Ludwig Aigner; Francisco J Rivera
Journal:  Stem Cells Dev       Date:  2011-12-23       Impact factor: 3.272

2.  TAPP1 inhibits the differentiation of oligodendrocyte precursor cells via suppressing the Mek/Erk pathway.

Authors:  Yidan Chen; Ruyi Mei; Peng Teng; Aifen Yang; Xuemei Hu; Zunyi Zhang; Mengsheng Qiu; Xiaofeng Zhao
Journal:  Neurosci Bull       Date:  2015-08-04       Impact factor: 5.203

3.  Catalpol induces oligodendrocyte precursor cell-mediated remyelination in vitro.

Authors:  Chun-Xiao Yuan; Takho Chu; Li Liu; Hao-Wen Li; Ya-Jie Wang; An-Chen Guo; Yong-Ping Fan
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

4.  Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy.

Authors:  Andrew C Eschenroeder; Allison A Vestal-Laborde; Emilse S Sanchez; Susan E Robinson; Carmen Sato-Bigbee
Journal:  Glia       Date:  2011-10-14       Impact factor: 7.452

5.  Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (Fgf2)-null mice: differential detection with diffusion tensor imaging.

Authors:  Jennifer E Tobin; Mingqiang Xie; Tuan Q Le; Sheng-Kwei Song; Regina C Armstrong
Journal:  J Neuropathol Exp Neurol       Date:  2011-02       Impact factor: 3.685

6.  Transgenerational attenuation of opioid self-administration as a consequence of adolescent morphine exposure.

Authors:  Fair M Vassoler; David J Oliver; Cristina Wyse; Ashley Blau; Michael Shtutman; Jill R Turner; Elizabeth M Byrnes
Journal:  Neuropharmacology       Date:  2016-10-08       Impact factor: 5.250

7.  AATYK is a Novel Regulator of Oligodendrocyte Differentiation and Myelination.

Authors:  Chunxia Jiang; Wanqing Yang; Zhihong Fan; Peng Teng; Ruyi Mei; Junlin Yang; Aifen Yang; Mengsheng Qiu; Xiaofeng Zhao
Journal:  Neurosci Bull       Date:  2018-03-19       Impact factor: 5.203

8.  Longitudinal Evaluation of Visual Function in Multiple Sclerosis.

Authors:  Divya Narayanan; Han Cheng; Rosa A Tang; Laura J Frishman
Journal:  Optom Vis Sci       Date:  2015-10       Impact factor: 1.973

9.  Immunity and inflammation in neurodegenerative diseases.

Authors:  Giuseppe Cappellano; Miryam Carecchio; Thomas Fleetwood; Luca Magistrelli; Roberto Cantello; Umberto Dianzani; Cristoforo Comi
Journal:  Am J Neurodegener Dis       Date:  2013-06-21

10.  Modeling links softening of myelin and spectrin scaffolds of axons after a concussion to increased vulnerability to repeated injuries.

Authors:  Aayush Kant; Victoria E Johnson; John D Arena; Jean-Pierre Dollé; Douglas H Smith; Vivek B Shenoy
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.